-+ 0.00%
-+ 0.00%
-+ 0.00%

Opus Genetics hosts R&D Science Forum highlighting inherited retinal disease gene therapy pipeline

PUBT·06/16/2026 20:05:39
Listen to the news
Opus Genetics hosts R&D Science Forum highlighting inherited retinal disease gene therapy pipeline
  • Opus Genetics hosted an R&D Science Forum on its inherited retinal disease gene therapy pipeline.
  • Management outlined five programs with four clinical readouts targeted in 2027, with RDH12, MERTK, RHO trials slated from Q4 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Opus Genetics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606161605PRIMZONEFULLFEED9748028) on June 16, 2026, and is solely responsible for the information contained therein.